Benchmark

Benchmark reiterates its Speculative Buy rating on Columbia Laboratories (NASDAQ: CBRX) and lowers its price target to $1.50 a share. It believes the after-close price on the stock provides an entry opportunity, despite uncertainly on regulatory terms. Benchmark says, " Friday January 20 the FDA...

Benchmark reiterates its Buy rating on RR Donnelly & Sons (NASDAQ: RRD) and lowers its price target to $16, down $3, as it trims estimates on lower sales. Benchmark notes, "Donnelley updated 2011 guidance. We lower our 2011 and 2012 revenue and EPS estimates. We maintain a Buy rating but...

According to Benchmark, eBay (NASDAQ: EBAY) Hold rating is reiterated. Benchmark said that eBay (EBAY-Hold, PT $37) is scheduled to report its 4Q11 results on Wednesday, January 18 after the stock market close. “eBay trades at 13x 2012E adjusted EPS, below ecommerce comparables at 25x and above...

According to Benchmark, BioClinica (NASDAQ: BIOC) price target is raised to $8. Benchmark said that it hosted an investor event at BioClinica's eClinical software headquarters in Audubon, PA on January 13. “We are increasing our price target to $8.00, from $7.00, to reflect a 20x multiple of our...

According to Benchmark, Amazon (NASDAQ: AMZN) price target is lowered to $210. Benchmark said that Amazon.com (AMZN-Buy, PT from $225 to $210) should report around 40% top-line 4Q11 growth, but ongoing margin impairment hindering profitability. “Our EPS projections: 4Q11E $0.21, 2011E $1.20, 2012E...

Benchmark reiterates its Buy rating and $36 target price on Ceva (NASDAQ: CEVA) as it expects fourth quarter revenue at high end of guidance range. Benchmark says, "Based on strong license and royalty trends, we believe CEVA should post 4Q11 revenue toward the upper end of its guidance range ($...

Benchmark maintains its Hold rating and $30 target price on Meredith Corporation (NYSE: MDP) as broadcast may help offset steep magazine advertising decline. Benchmark says, "We regard Meredith as one of the better-run companies in the media sector, given its strong balance sheet, dominant...

Benchmark reiterates its Buy rating and $65 target price on Warnaco (NYSE: WRC) as it lowers estimates on European woes. Benchmark says, "Warnaco reported net revenue increased slightly below 10% for the year, versus its guidance of 10% to 12% growth, and that EPS is now expected to be a couple...

Benchmark reiterates its Buy rating on JDA Software (NASDAQ: JDAS) and lowers its price target to $38 as the company pre-announces shortfall in licenses for the fourth quarter. Benchmark says, "Last night, JDAS reported preliminary 4Q11 results below our estimates and the Street consensus....

Benchmark initiates its coverage on Nielsen Holdings (NYSE: NLSN) with a Buy rating and a price target of $37 as the company's growth is driven by TV expansion and online and mobile audiences. Benchmark says, "We consider Nielsen a unique investment opportunity as the Company is a major provider...

Benchmark reiterates its Buy rating on InfoSpace (NASDAQ: INSP) and raises its target price to $14 from $11 to reflect the company's planned transformative, accretive acquisition. Benchmark says, "InfoSpace is making a major acquisition that is extremely accretive to EPS and FCF. The purchase of...

According to Benchmark, Cavium Networks (NASDAQ: CAVM) Hold rating is maintained. Benchmark said that Cavium lowered 4Q11 revenue and gross margin expectations. “We are lowering our 4Q11 revenue/EPS (non-GAAP) estimates from $61.6 million/$0.19 to $56.5 million/$0.13. We reiterate our Hold rating...

Benchmark lowers its rating on Manhattan Associates (NASDAQ: MANH) to Hold from Buy primarily due to its current valuation limiting near-term upside potential. Benchmark says, "MANH's shares have appreciated 40% ytd (vs. -8% for the broader software sector) and, since our April 2010 upgrade, are...

In a published report, Benchmark maintains its Buy rating and $45 target price on Travelzoo (NASDAQ: TZOO) as holidays spark local deals in December. Benchmark says, "Travelzoo's Local Deals likely accelerated following Thanksgiving through a combination of holiday deals, extended deals and new...

According to Benchmark, McClatchy Company (NYSE: MNI) Hold rating is maintained. Benchmark said that it is raising its 2011 and 2012 estimates for McClatchy (MNI-Hold rated) as a result of stronger than expected newspaper ad revenues and circulation in the closing months of the year. “Total...